Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Hutchi to launch SENQ following major Brisbane radio licence acquisition
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Hutchi to launch SENQ following major Brisbane radio licence acquisition
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Hutchi to launch SENQ following major Brisbane radio licence acquisition
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Hutchi to launch SENQ following major Brisbane radio licence acquisition
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Hutchi to launch SENQ following major Brisbane radio licence acquisition
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Wiseway achieves key milestone with Chinese fruit export accreditation
    • News

    Wiseway achieves key milestone with Chinese fruit export accreditation

    Freight forwarding company, Wiseway (ASX: WWG) is set to expand their international operations following the announcement that the company has been granted accreditation to export fruit directly to China. The news comes as the company signed an exclusive agreement with produce supplier and Chinese exporter, China Marketing Solutions. Export accreditation of the Melbourne and Sydney

    Read More
    Public
  • Medical Developments gains approval to commence Penthrox trials in China
    • News

    Medical Developments gains approval to commence Penthrox trials in China

    Australian pharmaceuticals manufacturer Medical Developments International (ASX: MVP) has secured approval from the Chinese National Medical Product Administration (NMPA) to commence bridging trials for Penthrox IND, their green whistle pain reliever.  The approval is a major step towards commercialisation of the flagship non-opioid pain reliever in China.  “The approval of the Penthrox IND by the

    Read More
    Public
  • Noni B secures EziBuy database for ‘nominal figure’, stake in company too
    • News

    Noni B secures EziBuy database for ‘nominal figure’, stake in company too

    Australian retailer Noni B (ASX: NBL) and Alceon Group have reached an agreement to purchase a 50.1% stake in EziBuy, a large multi-channel clothing and homewares retailer in New Zealand for an undisclosed “nominal” figure.  The purchase will provide Noni B and Alceon with the majority stake in EziBuy which last year reported NZD $135m

    Read More
    Public
  • Family Zone Cyber Safety expands to Indonesia with free smartphone monitoring service
    • News

    Family Zone Cyber Safety expands to Indonesia with free smartphone monitoring service

    Technology modeled on Family Zone Cyber Safety (ASX: FZO) is set to reach the Indonesian market, following news that a free monitoring service based on the Australian tech company’s model will be launched by Indonesia’s largest cellular operator, Telkomsel.  The technology branded ‘Telkomsel SAFE’, will be a free service which can be installed on a

    Read More
    Public
  • FDA relaxes clinical trial guidelines, opens U.S opportunity to Visioneering
    • News

    FDA relaxes clinical trial guidelines, opens U.S opportunity to Visioneering

    Medtech developer Visioneering Technologies (ASX: VTI) may soon have its NaturalVue Multifocal (NVMF) contact lenses re-classified by the FDA which has just approved the first contact lenses which slow the progression of nearsightedness.  The FDA approval was given to CooperVision’s MiSight® 1 day contact lens which slows the progression of myopia specifically in children. The

    Read More
    Public
  • ServTech launches virtual reality tech in Canada, capitalising on building activity
    • News

    ServTech launches virtual reality tech in Canada, capitalising on building activity

    With Toronto, currently in the midst of a mini housing boom which has seen rises in house prices and an influx of commercial development, Australian tech company ServTech Global (ASX: SVT) is set to launch their virtual reality (VR) and augmented reality (AR) software in Canada. The expansion comes via a software distribution agreement with

    Read More
    Public
  • XJO set to open flat after another US record
    • News

    XJO set to open flat after another US record

    The XJO has been toying with potential resistance at the 6,750 – 6,775 level, after breaking the level on Friday. If the XJO can break this resistance convincingly, we should eventually see the XJO continue higher towards the all-time high level at 6,875, which should be the next resistance. If we fall through 6,750, the

    Read More
    Public
  • HeraMED shares surge 51% following FDA approval for fetal heart monitor
    • News

    HeraMED shares surge 51% following FDA approval for fetal heart monitor

    Medtech company HeraMED (ASX: HMD) has seen a major spike in investor confidence after securing clearance from the US Food and Drug Administration (FDA) for HeraBEAT US – their fetal ultrasonic heart monitor.  Intended to detect, display and replay heart beats from as early as 12 weeks into pregnancy, the handheld device was developed in

    Read More
    Public
  • Medical cannabis adoption trend continuing in UK after Althea Group secures key licence
    • News

    Medical cannabis adoption trend continuing in UK after Althea Group secures key licence

    Australian-based Medical Cannabis producer and supplier, Althea Group (ASX: AGH), have announced this morning that their Bristol-based medical clinic site has secured a licence from a UK independent health and social care regulator. The news suggests that medical cannabis is becoming increasingly accepted in the UK as a treatment option for chronic health conditions.  Wholly

    Read More
    Public
  • Turners secures Heartland Bank as mass distribution partner for auto-insurance
    • News

    Turners secures Heartland Bank as mass distribution partner for auto-insurance

    New Zealand financial services provider Turners Automotive Group (ASX/NZX: TRA) has partnered with Heartland Bank (ASX/NZX; HGH), securing a new distribution network which the auto insurers expects to generate an additional NZ $2m in revenue.  Via the partnership, Heartland Bank will commence selling Turners’ Autosure products via their motor vehicle financing business, MARAC.  “This is

    Read More
    Public
  • «
  • ‹
  • 304
  • 305
  • 306
  • 307
  • 308
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.